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Purpose: To investigate the source of significant difference
in apparent diffusion coefficient (ADC) between patients
with acute symptoms of neuropsychiatric (NP) systematic
lupus erythematosus (SLE) (NPSLE) and normal controls.
Materials and Methods: Diffusion-weighted echo-planar
imaging was performed on 1.5-T scanners in 17 female and
four male NPSLE patients with acute neurological symp-
toms (23–76 years, mean  42.7 years), and in 21 aged-
matched healthy controls (16 female, five male, 26–63
years, mean  41.1 years). ADC histograms were calcu-
lated for whole brain, gray matter tissue, and white matter
tissue.
Results: Of the 17 NPSLE patients, 13 (72%) had abnormal
findings on MR imaging. The NPSLE patients had a mean
ADC value of (1105.1  23.6)  10—6 mm2/second and the
control had a mean ADC value of (1012.5  9.4)  106
mm2/second (P  0.0012). Significant differences were also
found in white matter (P  0.0020) and gray matter (P 
0.0022).
Conclusion: ADC histogram analysis demonstrated in-
creased general diffusivity in the brain in NPSLE patients
with acute symptoms compared with healthy normal con-
trols. This finding suggests that in the brain parenchyma of
NPSLE patients a loss of tissue integrity occurs facilitating
motility of free-water protons.
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NEUROPSYCHIATRIC (NP) systemic lupus erythemato-
sus (SLE) (NPSLE) occurs in 25% to 70% of patients
with lupus and is associated with increased morbidity
and mortality (1). The clinical manifestations of NPSLE
include psychosis, stroke, and epilepsy, in addition to
more subtle symptoms such as headache and neuro-
cognitive dysfunction (2). Patients with concomitant
antiphospholipid antibodies (APL-ab) are at additional
risk for neuropsychiatric events. Lupus patients are
also at increased risk for a wide range of central ner-
vous system (CNS) events related to immunosuppres-
sive therapy, including infection and drug toxicity, hy-
percoagulability, and accelerated atherosclerosis.
CNS vasculitis and/or cerebritis represent a poten-
tially severe form of NPSLE and may present with sei-
zures, movements disorders, altered consciousness,
stroke, and coma (3). While CNS inflammation is un-
common in SLE, the clinician nevertheless must enter-
tain this diagnosis any time a lupus patient presents
with CNS signs or symptoms. Although clinical assess-
ment is the keystone in the diagnosis of NPSLE, the
diagnosis is often difficult and remains presumptive in
some patients. MR imaging findings are variable and in
some cases the MRI is unremarkable (4–9).
Lately, by using advanced techniques as proton MR
spectroscopy, single photon emission CT (SPECT), T2
relaxometry, and magnetization transfer imaging (MTI),
cerebral abnormalities are found in patients with
NPSLE who present with diffuse symptoms. Diffusion-
weighted imaging (DWI) is another technique that can
depict cerebral abnormalities when conventional MRI
fails to do so. DWI is a well established method that is
implemented as a part of routine protocol at many in-
stitutions around the world. DWI measures the diffu-
sivity of visible water molecules (10) and the principles
for the measurement of diffusion with magnetic reso-
nance imaging (MRI) are well described (11,12). DWI
has shown to be a very useful tool for early signs of
ischemia (13,14) before changes are present on conven-
tional T2-weighted or fluid attenuation inversion recov-
ery (FLAIR) images, but is also increasingly used in the
evaluation of other brain diseases, e.g., multiple scle-
rosis (15–17), trauma (18,19), brain tumor (20,21), and
hypertensive encephalopathy (22,23), among others.
Histogram analysis of apparent diffusion coefficient
(ADC) values in brain of multiple sclerosis patients have
illustrated significant differences compared to normal
controls (25,26). A recent study has demonstrated the
use of volumetric quantitative DWI analysis in NPSLE
1Department of Radiology, University Hospital of Michigan, Ann Arbor,
Michigan, USA.
2Department of Radiology, Vienna University Hospital, Vienna, Austria.
*Address reprint requests to: R.C.W., Department of Radiology, Basic
Radiological Sciences Division, Kresge III, Room 3315, 200 Zina Pitcher
Place, Ann Arbor, MI 48109-0553. E-mail: rcwelsh@med.umich.edu
Received March 7, 2006; Accepted May 3, 2007.
DOI 10.1002/jmri.21036
Published online in Wiley InterScience (www.interscience.wiley.com).
JOURNAL OF MAGNETIC RESONANCE IMAGING 26:541–551 (2007)
© 2007 Wiley-Liss, Inc. 541
patients with diffuse symptoms (24). They demon-
strated higher ADC values and significantly lower and
broader ADC histograms in the NPSLE patients with
diffuse, but no acute, clinical symptoms (e.g., no focal
or regional signal abnormalities on diffusion weighted
images) compared to normal controls (24). We hypoth-
esized that cerebral changes in NPSLE patients with
acute new onset of neurological symptoms might be
detectable and quantifiable by the means of ADC his-
togram analysis.
The aim of the present study was to investigate
whether volumetric quantitative DWI analysis can de-
pict cerebral abnormalities in patients with acute
symptoms of NPSLE and if significant differences in
measured whole-brain ADC histograms between these
patients and normal controls exist. Additionally, we
investigate the ADC distributions in white matter only
and gray matter only to further the understanding of
observed whole-brain ADC distribution differences.
MATERIALS AND METHODS
Patients
A total of 21 patients (17 female, four male), aged 23–76
years, mean  42.7 years, were included in this pro-
spective study. Patients were included if they: 1) ful-
filled the 1982 Revised criteria for SLE set forth by the
American Rheumatism Association (27); and 2) had
new onset of neurological symptoms suspected to be
related to their known SLE within a week prior to the
initial examination. All patients underwent conven-
tional MR of the brain within 24 hours of admission to
the hospital. Follow-up MRI examinations in a limited
number of patients were performed three and six
months after the initial study. All work that was related
to this research was performed in accordance with our
institutional review boards and with the expressed in-
formed consent of the participants. Of the 21 patients,
11 (11 female, 0 male) were seen at the first site, and the
remaining 10 patients (six female, four male) were
scanned at the second site. One of the patients from the
second site (female) demonstrated a large lesion on MR
imaging and was subsequently removed from further
analysis. The remaining 20 patients are reported here.
A group of 21 (16 female, five male) aged-matched
normal controls were used for comparison. All of the
controls were scanned at the first site.
MR Imaging
The MR examinations were performed on a 1.5-T scan-
ner (GE Medical Systems) at the first site and on a 1.5-T
scanner (Philips Medical System) at second site. The
conventional MRI examination included: pre- and post-
contrast-enhanced axial and sagittal T1-weighted im-
ages, axial T2-weighted images with fat saturation, ax-
ial FLAIR and DWI images (spin-echo echo-planar
imaging [SE-EPI]; b  1000 seconds/mm2; in three
directions: slice, frequency, and phase-encode, com-
bined on the scanner to produce isotropically-weighted
DWI and T2-weighted images), and post-contrast-en-
hanced T1-weighted images in the coronal projection. A
total of 20 mL of Gd-diethylene triamine pentaacetic
acid (DTPA) (Magnevist, Berlex Laboratories, USA) was
intravenously injected before post-contrast-enhanced
images.
The MR images were evaluated for brain volume loss
(none, mild, moderate, or severe), abnormal signal, ab-
normal contrast enhancement, abnormal diffusion,
presence of hemorrhage or mineralization, and any ad-
ditional abnormalities. Brain lesions were either classi-
fied as infarct-like (moderate to large-sized, roughly
wedge-shaped areas of increased T2/FLAIR intensity,
and/or encephalomalacia involving gray and white
matter) or white matter lesions (further categorized as
subcortical, deep, periventricular, punctate, or patchy).
Lesions were further characterized as to location and
number. Serial imaging was evaluated to characterize
lesions as stable, improving, or progressing. Diffusion-
weighted images were examined for areas of restricted
or increased diffusion, with ADC maps utilized
Clinical data for each patient was extracted via a
focused search of our institution’s computerized data
record, including patient demographics (age, sex, and
race), disease characteristics (primary and secondary
diagnoses, duration of diagnosis, medications, and
presence of APL-ab, clinical symptoms, neurological di-
agnosis, pathologic diagnosis, therapy, and clinical
course.
Summary demographics and clinical characteristics
of the 20 patients entered into the study are presented
in Table 1. Presenting symptoms for each patient were
classified according to the 1999 American College of
Rheumatology Nomenclature and Case Definitions for
Neuropsychiatric Lupus Syndromes (3) and are sum-
marized in Table 2.
DWI and ADC
Whole-brain ADC histograms were calculated in all
subjects (patients and normal controls). To remove re-
gions outside of the brain, as well as removing contri-
butions from the cerebellum, masks (referred to as the
“cortical mask”) were drawn for each subject using a
MATLAB tool. The ADC was calculated in the remaining
regions according to ADC  logIo/Ib/b, where I0 is the
non-diffusion-weighted T2 (b  0 seconds/mm2) image
and Ib is the diffusion-weighted image with weighting
b  1000 seconds/mm2. Due to the nature of this
study, individual diffusion-weighted images (slice, fre-
quency, and phase) were not extracted from the scan-
ner, only the combined isotropically-weighted image
and b  0 seconds/mm2 image. However, both sites
undergo routine careful quality assurance for eddy cur-
rent compensation. As a post hoc test of residual dis-
tortion and potential subject motion, DWI images were
affine corrected to the T2-weighted image using McFlirt
(28). All affine matrices illustrated less than 1% distor-
tion on average in the DWI images. Subject motion was
much less than a voxel in any given direction. Given
these results, ADC images were calculated from the
non-affine-corrected data.
To explicitly remove cerebrospinal fluid (CSF), a small
region of interest (ROI) was drawn in the ventricles of
each subject’s b  0 seconds/mm2 image (T2). The
mean value of this ROI was used to determine a thresh-
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old (85% of mean CSF value in the b  0 ROI) to further
define a CSF mask (the “csf-exclusion-mask”), as pre-
viously done by Bosma et al (24). This was performed
subject-by-subject. Finally, the T2 image (the b  0
seconds/mm2 image of the DWI sequence) was seg-
mented (29) into gray, white, and CSF compartments
using the segmentation routines in SPM99. By seg-
menting this T2 image, the resulting gray, white, and
CSF segments are, by definition, coregistered to the
ADC image. The segmentation results in three proba-
bility likelihood images: 1) the likelihood that a voxel is
gray matter; 2) the likelihood that a voxel is white mat-
ter; and 3) the likelihood that a voxel is CSF. Gray
matter (the “gray mask”) and white matter (the “white
mask”) masks were initially constructed using a con-
servative threshold of 0.85 on the likelihood value. A
combined whole “brain mask” was mathematically de-
fined as the intersection of the cortical mask, the csf-
exclusion mask, and the union of the gray mask and
white mask. To further investigate any differentiation
between gray matter diffusion and white matter diffu-
sion, two additional masks were constructed: 1) a “gray
only mask” being the intersection of the cortical mask,
the csf-exclusion mask, and the gray mask; and 2) a
“white only mask” being the intersection of the cortical
mask, the csf-exclusion mask, and the white mask.
An issue to address is partial volume effects. Due to
the finite spatial sampling inherent in any imaging
technique, voxels can be of mixed tissue type, i.e., con-
taining mainly a single tissue type but a fraction may be
CSF. That is, if a gray matter voxel contained a fraction
of gray matter (fGray) with a diffusion value of ADCGray
and fCSF of CSF with a diffusion value of ADCCSF, the
observed ADC value in that voxel would be:
ADCObs  fGray  ADCGray  fCSF  ADCCSF.
Given that the ADC of CSF is 2 to 3 times that of gray
matter, then an increased effective value of ADC would
be observed for a gray matter voxel that contains a
fraction of CSF. To investigate if previously observed
increases (24) in ADC are due to partial voluming of
CSF, a further refinement of tissue definition was im-
posed. To further the definition of gray matter and white
matter, a “neighborhood-like” function was evaluated
for each voxel: a tissue was classified by its likelihood
due to segmentation as well as the likelihood classifi-
cation of its nearest neighbors. The resulting neighbor-
hood-like value ranged from 0 (no like neighbors) to 26
(all like neighbors). Hence, a gray matter voxel sur-
rounded by more gray matter voxels will have less par-
tial volume effects and contribute more cleanly to a
measure of gray matter diffusivity, likewise for a white
matter voxel. Given that white matter is bulky, we can
expect a white matter voxel to exhibit more like neigh-
bors than a gray matter voxel.
Whole-brain histograms, gray matter only histo-
grams, and white matter only histograms were calcu-
lated for each subject. These histograms were normal-
ized to unit area. The mean ADC, the width (standard
deviation [SD]) of the ADC distributions, the left to right
distribution (skewness), and how extended the histo-
gram was (kurtosis) was evaluated in each subject.
Group averages and standard errors of these metrics
were then calculated across subjects. A P value  0.05









Race Diagnosis Durationa APL/APLb
1 Female 45 W SLE 16 years 
2 Female 46 W SLE 20 years 
3 Female 32 W SLE 23 years 
4 Female 59 AA SLE 	5 years 
5 Female 44 AA SLE 	5 years 
6 Female 52 W SLE 14 years 
7 Female 41 W SLESjogren 10 years 
8 Female 55 W SLESjogren 	10 years 
9 Female 23 As SLE 6 month 
10 Female 45 AA SLE 19 years 
11 Female 46 W SLESjogren 13 years 
12 Male 76 W SLE 	5 years 
13 Female 62 W SLESjogren 32 years 
14 Male 31 W SLE 12 years NA
15 Female 29 W SLE 3 years 
16 Female 39 W SLE 1 years NA
17 Male 29 W SLE 18 years 
18 Female 46 W SLE 	3 years 
19 Female 28 W SLESjogren 	3 years 
20 Male 37 W SLE 	3 years 
*Patient demographics including diagnosis, duration of disease, and presence or absence of antiphospholipid antibodies (APL-Ab). Patients
4, 7, and 10 were excluded from spectroscopy statistics as final clinical diagnosis did not confirm NPSLE.
aDuration of disease at the time of the initial MRI study.
bPresence of antiphospholipid antibodies (APL-Ab) (/).
AA  Afro-American, As  Asian, W  white., NA  not applicable.
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Histograms by group, SLE, and normal controls were
then calculated by averaging the unit-normed histo-
grams across the subjects.
RESULTS
Based on clinical criteria, 17 out of the 20 SLE patients
were classified as NPSLE at the final diagnosis. As this
study concerns patients with acute onset of NPSLE, the
results are dealing only with these 17 patients and 21
controls, except for Tables 1, 2, and 3, which present all
20 of the SLE patients that entered the study. Of the 17
patients, six patients were followed over time and un-
derwent examinations at three and six months as well,
and two patients underwent a follow-up study at three
months but declined to participate in the final follow-up
examination six months after the initial study. All the
patients that had follow-up scans were examined at the
first site.
Six of the eight patients underwent all three exami-
nations and, therefore, completed the study. Two pa-
tients underwent two of the examinations, but declined
to participate in the final follow-up examination six
months after the initial study. In these eight patients,
the cause of their acute symptoms was confirmed as
lupus with CNS involvement. In the remaining three
patients, who are not included into the proper study of
NPSLE, the likely etiology to their symptoms was be-
lieved to be drug related (patient 4), orthostatic (patient
10), and dissociative fugue/conversion disorder (pa-
tient 7) (Table 2). Seven of the 17 patients were antipho-
solipid antibody-positive (APL-ab) and eight were neg-
ative (APL-ab–) (Table 1). In two of the 17 patients no

















None Improved Ischemic event, lupus cerebritis
3 Acute left weakness Methylprednisolone Improved Lupus cerebritis
4 Mental status decline,
increased tremor
Multiple medications. No additional
medication
Improved Drug related symptoms
5 Cognitive dysfunction,
history of seizures






None Unchanged Dissociative fugue, conversion disorder,
8 Increased tremor,
tics, diplopia
Prednisone Improved Lupus cerebritis











Methylprednisolone, prednisone Improved Lupus cerebritis
12 Disorientation,
agitation,
Multiple medications. No additional
medication
Improved Lupus cerebritis
13 Acute left sided
hypesthesia
Prednisolone Unchanged Lupus cerebritis
14 Headache NA NA Unclear etiology most likely lupus
cerebritis
15 Fatigue NA NA Unclear etiology most likely lupus
cerebritis
16 History of seizures None Unchanged Lupus cerebritis
17 Mild mental status
decline
None Unchanged Lupus cerebritis
18 Acute left paresis,
headache,
dysarthria




Methylprednisolone Improved Lupus cerebritis
20 Headache, difficulties
finding words
Prednisolone Improved Lupus cerebritis
*Clinical symptoms at time of presentation, medical treatment, and interval change in clinical symptoms and final diagnosis for this event of
acute symptoms for the 20 SLE patients.
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tients, 12 (71%) had major neuropsychiatric symptoms,
such as cognitive problems, weakness, visual prob-
lems, and meningismus. Six patients (29%) had head-
ache and/or mild cognitive complaints, such as diffi-
culties in concentration, memory, or word finding as
the only problem at time of the initial study. Morpho-
logical brain abnormalities were seen in nine of the 12
patients with major neuropsychiatric symptoms and in
four patients with minor neuropsychiatric symptoms
on conventional MRI. Eleven patients had some medical
treatment for SLE prior to the initial study, most com-
monly prednisone .
On the whole, 12 of the 17 patients received addi-
tional medication after the initial admission; methyl-
prednisolone (five patients), prednisone (six patients),
and cyclophosphamide (one patient). The remaining six
patients received no additional medication. In the
group of eight patients that had additional follow-up
MR scanning, seven patients were treated with addi-
tional medication after the initial admission: methyl-
prednisolone (four patients), prednisone (two patients),
and cyclophosphamide (one patient). The remaining pa-
tient received no additional medication. Of the 17 pa-
tients with NPSLE, 11 (65%) had clinical response/
improvement, whereas six patients (35%) did not
improve (Table 2).
MR Imaging of the Brain
Imaging findings are summarized in Table 3. Of the 17
patients, 12 (71%) had abnormal findings on MR imag-
ing. The most common findings were scattered single or
multiple foci (seven patients) or patchy areas (four pa-
tients) of increased signal on T2-weighted or FLAIR im-
ages in the deep and periventricular white matter, with
no pathological contrast enhancement. Other abnor-
mal findings included focal foci of increased signal on
DWI images, consistent with restricted diffusion in focal
acute ischemia (two patients), volume loss or brain at-
rophy (mild in three and moderate in two patients), old
small infarctions (two patients), and meningeal en-
hancement (one patient). Incidental note was made of
small meningiomas in two patients
ADC Histograms
The whole-brain ADC histogram analysis revealed that
the NPSLE patients had a mean ADC value of (1105.1 
23.6)  106 mm2/second and the controls a mean
value of (1012.5  9.4)  106 mm2/second. The mean
ADC values were significantly higher (P  0.0012, two-
tailed) in the NPLSE patients compared to the controls.
These data are summarized in Figs. 1–4. The group
averaged whole-brain (without CSF) ADC histograms
are in Fig. 1, clearly illustrating the group differences.
The gray matter only and the white matter only ADC
histograms for the groups are in Figs. 2 and 3, respec-
tively. The gray matter ADC means, (1033.6  24.3) 
106 mm2/second for NPSLE and (944.2  10.8) 
106 mm2/second for normal controls, are significantly
different (P  0.0022, two-tailed) between the groups.
The white matter only ADC histograms also demon-
strated a significance difference in mean ADC values,
(768.6  10.1)  106 mm2/second for NPSLE and
(730.5  5.3)  106 mm2/second for normal controls,





Initial study at time of presentation of symptoms
1 Normal (0)
2 Scattered small bilateral nonspecific WM foci, mild brain volume loss (1)
3 Scattered small foci of signal alterations in WM and GM, moderate brain volume loss (2)
4 Patchy T2-signal abnormalities in bilateral periventricular WM, abnormal DWI in the left basal ganglia, mild
brain volume loss (1), old small infarcts
5 Scattered small foci of increased T2 signal in bilateral WM (0)
6 Old well defined smaller infarct left frontal lobe, multiple small scattered areas of increased T2 signal, mild
brain volume loss (1)
7 Mild brain volume loss (1)
8 Diffuse subcortical and periventricular WM and brainstem signal abnormality, general moderate loss of brain
volume (2)
9 Patchy areas of increased T2 signal in the WM of both hemispheres, petechial hemorrhage (0)
10 Scattered small foci of increased T2 signal in bilateral WM, small meningioma (0)
11 Scattered small foci of increased T2 signal in bilateral WM, meningeal enhancement (0)
12 Patchy areas of increased T2 signal in bilateral WM (0)






19 Scattered small foci of increased T2 signal in bilateral WM (0)
20 Old smaller infarcts bilateral-occipital-parietal, basal ganglia left old defect, new abnormal DWI  lesions (0)
*Findings at the MRI of the brain in each of the 20 SLE patients entering the study at the initial examination. Patients 4, 7, and 10 were
excluded from the final evaluation as described in the main text. Brain loss is indexed in parentheses as: none  0, mild  1, moderate 
2, and severe  3.
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ues, as well as the SD of individual ADC histograms, are
plotted in Fig. 4. The difference in the widths of the
whole-brain ADC distributions between the NPSLE and
normal controls stems from differences in the gray mat-
ter distributions between the two groups. The signifi-
cance difference of the widths when examining the
whole-brain ADC histograms is P  0.026, while in the
gray matter it is only P  0.0068, and the white-matter
only distributions do not appear to have significantly
different widths, P  0.338.
To investigate the effect of surrounding tissue (gray,
white, or CSF) on the ADC distributions, the neighbor-
hood-like function was used to further refine the defi-
nition of white matter and gray matter. Two values of
the neighborhood-like function were evaluated for fur-
ther definition—a value of seven (a moderate constraint
on likeness) and a value of 15 (a stringent constraint on
likeness). In other words, a voxel of gray matter was
only used for the histogram if it had at least seven
gray-like neighbors and 15 gray-like neighbors. This
criterion was also used for white matter. The resulting
ADC histograms for seven neighbors and 15 neighbors
are shown in Figs. 5 and 6 for gray matter and white
matter, respectively. The individual mean ADC values
for each subject are plotted in Fig. 7. As can be seen, the
white matter distributions change very little with in-
creasing definition of white matter as determined by the
neighborhood-like function. This is mainly due to there
being a larger fraction of bulk white matter relative to all
white matter in the brain as compared to the fraction of
bulk gray matter in the human brain. For a neighbor-
hood-like value of seven, the observed mean gray mat-
ter ADC in NPSLE is (1000.1  22.1)  106 mm2/
second, a decrease of approximately 3%. While in the
normal controls, the observed ADC mean becomes
(924.9  10.0)  106 mm2/second, a decrease of 2%,
there still is a significant difference observed in the ADC
means between the two groups (P  0.0041). Under the
tighter definition of gray matter, using a neighborhood-
like value of 15, the difference in ADC means, (910.6 
17.5)  106 mm2/second for NPSLE and (869.8 
9.5)  106 mm2/second for normal controls, is still
significant, though much less so, at P  0.044. There is
Figure 1. Comparison of whole-brain (excluding CSF) ADC
histograms between normal controls (filled circles and solid
line) and NPSLE patients (open diamonds and dashed line).
Standard error bars are calculated from group variance in
each histogram bin. Inserts show idealized line plots for clarity
of difference away from peak. Histograms are normalized to
unit area.
Figure 2. Comparison of normal controls (filled circles and
solid line) and NPSLE patients (open diamonds and dashed
line). Standard error bars are calculated from group variance
in each histogram bin. Inserts show idealized line plots for
clarity of difference away from peak. Histograms of ADC are for
gray matter tissue only. No neighborhood-like requirement
made. Gray matter voxel defined by segmentation likelihood
value 0.85.
Figure 3. Comparison of normal controls (filled circles and
solid line) and NPSLE patients (open diamonds and dashed
line). Standard error bars are calculated from group variance
in each histogram bin. Inserts show idealized line plots for
clarity of difference away from peak. Histograms of ADC are for
white matter tissue only. No neighborhood-like requirement
made. White matter voxel defined by segmentation likelihood
value 0.85.
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also still a significant difference (P  0.0063) in the
widths of the gray matter ADC distributions, (181.3 
16.0)  106 mm2/second for NPSLE and (131.4 
5.0)  106 mm2/second for normal controls.
The neighborhood-like influence on the white matter
distributions is less marked, with the NPSLE mean
ADC values being (762.9  9.4)  106 mm2/second
and (760.8  9.8)  106 mm2/second for neighbor-
hood-like values of seven and 15 respectively. For nor-
mal controls, the mean white matter ADC value does
not change, (729.6  5.3)  106 mm2/second and
(726.1  5.3)  106 mm2/second for neighborhood-
like values of seven and 15, respectively. The two
groups maintain significance difference, P  0.0023
and P  0.0026, for neighborhood-like values seven and
15. Table 4 summarizes these statistical results.
DISCUSSION
Our results of significantly increased ADC values on
whole-brain ADC histograms are in agreement with a
previous study (24). It seems that these findings do not
only occur in NPSLE patients with diffuse symptoms
with no focal or regional signal abnormalities seen on
the DWI (24), but also in NPSLE patients with acute
onset of neurological symptoms and with, as here pre-
sented, signal abnormalities on DWI (two patients) con-
sistent with acute ischemic changes, and, therefore,
most likely reflects permanent cerebral alterations seen
in this patient group regardless of severity or duration
of neurological symptoms. We also observe that these
increases in ADC values are found in gray matter only
and white matter only, indicating that the cerebral al-
terations is not limited to one tissue compartment.
It seems less likely that the, in general, small or, in
few cases, patchy white matter hyperintensities that
were present on the conventional T2-weighted and
FLAIR images in some of the patients would be respon-
sible for the significantly different diffusion pattern in
NPSLE because they were in general small in number
and size. Only in two of the patients were there small
foci of restricted diffusion (seen as increased signal on
the DWI; b  0 seconds/mm2 image) and not present on
the conventional T2-weighted or FLAIR images. This is
Figure 4. Individual mean values of individual ADC histograms and SDs of individual ADC histograms for gray matter and white
matter tissue respectively. Boxes indicate  SD about the group mean.
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a finding consistent with acute ischemia. In addition, to
eliminate the possibility of influence of larger CSF vol-
umes or edema, one patient with a large infarct was
excluded from the study before any measurements
were performed.
It has been suggested that the abnormal findings
seen in the brain of NPSLE patients are not related to
hypoxic/anaerobic events, but, rather, indicate a host
response to injury, such as an inflammatory reaction,
membrane activation, or demyelination (30). Such a
theory can be supported by histopathology studies in
which gliosis and demyelination has been described in
the brain parenchyma of patients with NPSLE (31). Vas-
culopathy, which is a common abnormality described
in NPSLE patients (32–34), might lead to altered cere-
bral blood flow as previously demonstrated with PET
and SPECT in NPSLE patients (35–39). An altered cere-
bral blood flow might lead to metabolic abnormalities
and axonal loss and associated demyelination, which
have been suggested in MR spectroscopy studies and
MTI studies (40–42).
The probability of such a pathogenetic pathway is
also supported by the MR spectroscopy findings seen in
eight of our 18 NPSLE patients (43). That study dem-
onstrated significant decreased N-acetyl aspartate
(NAA)/choline (Cho) ratios with further decrease over
time, an interval decrease of NAA/creatinine (Cr) over
time, and significantly elevated Cho/Cr and lactate/
lipids (LL)/Cr ratio at presentation, with no interval
change over time compared to normal controls. The
Figure 5. Comparison of normal controls (filled circles and solid line) and NPSLE patients (open diamonds and dashed line) gray
matter tissue and white matter tissue ADC histograms with increased neighborhood-like function, seven like-neighbors.
Standard error bars are calculated from group variance in each histogram bin. Inserts show idealized line plots for clarity of
difference away from peak.
Figure 6. Comparison of normal controls (filled circles and solid line) and NPSLE patients (open diamonds and dashed line) gray
matter tissue and white matter tissue ADC histograms with increased neighborhood-like function, 15 like-neighbors. Standard
error bars are calculated from group variance in each histogram bin. Inserts show idealized line plots for clarity of difference
away from peak.
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decline in NAA is suggested to be a sign of neuronal
loss, whereas an increase in the choline compounds
can be assumed to be a sign of increased metabolic
turnover/activity. These MRS findings, previously dem-
onstrated in our patients (43), further support the the-
ory of permanent axonal loss and associated demyeli-
nation.
The increased ADC values seen in the present study
in the 17 NPSLE patients could be explained by reduced
structural integrity with permanent loss of neurons and
demyelination. This will allow the interstitial water mol-
ecules to move freely in a less restricted environment.
This assumption is also suggested by others, with sim-
ilar findings of abnormal ADC in NPSLE patients (24). If
there is a breakdown of the myelin, as suggested by
abnormal values of the metabolite choline seen in MR
spectroscopy performed in some of our patients, the
ADC value would also increase. Normally, the ADC val-
ues decrease by the restriction of motion in a particular
direction. The myelin sheets form such a boundary and
if they breakdown ADC will increase. The observation
that there is increased ADC in white matter only, and
that this observation is stable regardless of the neigh-
borhood-like function, is consistent with a change in
the myelin. Additionally, given that there appears to be
no specific locale associated with the increased ADC
observed in the white matter, this is a systemic effect.
Using diffusion tensor imaging and the subsequent an-
isotropy measures in the future will provide for better
evaluation of these hypotheses.
The observed increase in gray matter ADC appears
somewhat dependent on the definition of a gray matter
voxel. As the neighborhood-like function is made more
stringent, the differences in mean ADC value between
NPSLE patients and normal controls begins to diminish
and, at the tightest definition of gray matter, the ADC
difference loses significance. This could be due to some
influence of partial voluming with CSF; however, at the
mid-definition of gray matter, all ADC measures (mean,
SD, skew, and kurtosis) remain significantly different
between the NPSLE patients and normal controls. This
result can be interpreted as consistent with inflamma-
tion and/or vasculitis of the gray matter. However, ac-
quiring high-resolution 3D T1- or T2-weighted images
in future studies will aid in addressing this issue.
Figure 7. Individual mean values of ADC histograms for gray matter and white matter tissue, respectively, with increased
neighborhood-like function. Left side for seven like-neighbors and right side for 15 like-neighbors. Boxes indicate  SD about
the mean.
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One of the limitations with this study is that we have
not performed specific brain volume segmentation for
brain volume loss. However, only four of the 17 NPSLE
patients finally evaluated in this study (patients 4, 7,
and 10 where excluded as mentioned earlier) had brain
atrophy, which was considered mild in two patients
with only mild prominence of sulci over the convexity,
slightly more then expected for patients age but without
obvious/visible loss of gray matter, especially, and
moderate in two patients. However, by constraining the
definition of gray matter with the neighborhood-like
function, and by further normalizing each subjects
ADC histogram independently, issues of atrophy are
mitigated. And, even with these tighter definitions of
gray matter and white matter, we still observe statisti-
cally significant differences between groups.
Therefore, we are presently conducting such studies
and are also combining the different available tech-
niques such as MR spectroscopy and MR perfusion to
be able to better understand and explain the underlying
pathophysiology behind these changes seen in NPSLE
patients.
Combining data from two separate sites can be prob-
lematic. To determine if observed differences in the ADC
histograms between controls and patients are being
driven by one of the imaging sites, we performed an
explicit statistical comparison of ADC histograms of
controls (21 controls from site one and nine controls
from site two) between sites and the included patients
in this study between sites. A Kolmogorov-Smirnov test
statistic (44) was calculated between groups for whole
brain, gray matter only, and white matter only. In each
case the null hypothesis was accepted (i.e., ADC distri-
butions are drawn from same parent sample), thus in-
dicating nonsignificant difference between sites. Addi-
tionally, a Student’s t-test statistic was calculated
between sites for the two groups (controls and patients)
separately for mean observed values of ADC. No statis-
tically significant difference was found, again indicating
that controls from either site are equivalent and that
patients from either site are equivalent.
In conclusion, ADC histogram analysis demonstrated
increased general diffusivity in the brain in NPSLE pa-
tients with acute neurological symptoms as compared
with healthy normal controls. This finding suggests
that in the brain parenchyma of NPSLE patients a loss
of tissue integrity occurs and facilitates motility of free-
water protons. Using segmented ADC histograms, this
observed loss of tissue integrity has been observed in
gray matter tissue and white matter tissue, separately.
However, larger studies are needed to evaluate the
present method for its value to study disease progres-
sion or its use in treatment control.
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